• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过神经常微分方程模型从稀疏多模态数据预测阿尔茨海默病进展

Predicting Alzheimer's Disease Progression from Sparse Multimodal Data by NeuralODE Models.

作者信息

Zanin Andrea, Pagani Stefano, Corti Mattia, Crepaldi Valeria, Di Fede Giuseppe, Antonietti Paola F

机构信息

IoTique, V.le Trento 37D, Rovereto, 38062, TN, Italy.

MOX, Department of Mathematics, Politecnico di Milano, Piazza Leonardo da Vinci 32, Milano, 20133, MI, Italy.

出版信息

bioRxiv. 2025 Aug 27:2025.08.26.672412. doi: 10.1101/2025.08.26.672412.

DOI:10.1101/2025.08.26.672412
PMID:40909652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12407814/
Abstract

Alzheimer's disease shows significantly variable progressions between patients, making early diagnosis, disease monitoring, and care planning difficult. Existing data-driven Disease Progression Models try to tackle this issue, but they usually require sufficiently large datasets of specific diagnostic modalities, which are rarely available in clinical practice. Here, we introduce a new modeling framework capable of predicting individual disease trajectories from sparse, irregularly sampled, multi-modal clinical data. Our method uses (recurrent) Neural Ordinary Differential Equations to determine the current hidden state of a patient from sparse past exams and to forecast future disease progression, illustrating how biomarkers evolve over time. When applied to the ADNI clinical cohort, the model detected early signs of disease more accurately than common data-driven alternatives and effectively tracked changes in biomarker trajectories that align with established clinical knowledge. This provides a versatile tool for accurate diagnosis and monitoring of neurodegenerative diseases.

摘要

阿尔茨海默病在患者之间表现出显著不同的进展情况,这使得早期诊断、疾病监测和护理规划变得困难。现有的数据驱动疾病进展模型试图解决这个问题,但它们通常需要足够大的特定诊断方式数据集,而这些数据集在临床实践中很少能获得。在此,我们引入了一个新的建模框架,该框架能够从稀疏、不规则采样的多模态临床数据中预测个体疾病轨迹。我们的方法使用(循环)神经常微分方程,根据过去稀疏的检查结果确定患者当前的隐藏状态,并预测未来的疾病进展,展示生物标志物如何随时间演变。当应用于阿尔茨海默病神经影像学计划(ADNI)临床队列时,该模型比常见的数据驱动替代方法更准确地检测到疾病的早期迹象,并有效地跟踪了与既定临床知识相符的生物标志物轨迹变化。这为准确诊断和监测神经退行性疾病提供了一个通用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/b7b3428ee2d7/nihpp-2025.08.26.672412v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/a0d59b9d0b11/nihpp-2025.08.26.672412v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/01890a3c8aa4/nihpp-2025.08.26.672412v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/317c14b781f4/nihpp-2025.08.26.672412v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/32ff51dce0e3/nihpp-2025.08.26.672412v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/edc31fd1e28a/nihpp-2025.08.26.672412v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/8daf206e17a6/nihpp-2025.08.26.672412v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/b7b3428ee2d7/nihpp-2025.08.26.672412v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/a0d59b9d0b11/nihpp-2025.08.26.672412v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/01890a3c8aa4/nihpp-2025.08.26.672412v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/317c14b781f4/nihpp-2025.08.26.672412v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/32ff51dce0e3/nihpp-2025.08.26.672412v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/edc31fd1e28a/nihpp-2025.08.26.672412v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/8daf206e17a6/nihpp-2025.08.26.672412v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81a/12407814/b7b3428ee2d7/nihpp-2025.08.26.672412v1-f0007.jpg

相似文献

1
Predicting Alzheimer's Disease Progression from Sparse Multimodal Data by NeuralODE Models.通过神经常微分方程模型从稀疏多模态数据预测阿尔茨海默病进展
bioRxiv. 2025 Aug 27:2025.08.26.672412. doi: 10.1101/2025.08.26.672412.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Fabricating mice and dementia: opening up relations in multi-species research制造小鼠与痴呆症:开启多物种研究中的关联
4
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
5
A Cross-Modal Mutual Knowledge Distillation Framework for Alzheimer's Disease Diagnosis: Addressing Incomplete Modalities.一种用于阿尔茨海默病诊断的跨模态互知识蒸馏框架:解决模态不完整问题。
medRxiv. 2024 Oct 22:2023.08.24.23294574. doi: 10.1101/2023.08.24.23294574.
6
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
7
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
8
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
9
Short-Term Memory Impairment短期记忆障碍
10
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

本文引用的文献

1
Survival Differences Between Individuals With Typical and Atypical Phenotypes of Alzheimer Disease.阿尔茨海默病典型与非典型表型个体之间的生存差异。
Neurology. 2025 May 27;104(10):e213603. doi: 10.1212/WNL.0000000000213603. Epub 2025 Apr 28.
2
Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia.解释无痴呆记忆门诊患者阿尔茨海默病体液生物标志物浓度的可变性。
Neurology. 2024 Apr 23;102(8):e209219. doi: 10.1212/WNL.0000000000209219. Epub 2024 Mar 25.
3
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box.
神经退行性疾病进展的数据驱动建模:跳出黑箱思维
Nat Rev Neurosci. 2024 Feb;25(2):111-130. doi: 10.1038/s41583-023-00779-6. Epub 2024 Jan 8.
4
An Approach to Binary Classification of Alzheimer's Disease Using LSTM.一种使用长短期记忆网络(LSTM)对阿尔茨海默病进行二元分类的方法。
Bioengineering (Basel). 2023 Aug 9;10(8):950. doi: 10.3390/bioengineering10080950.
5
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.有认知主诉的受试者中血浆和 PET 成像 ATN 标志物的头对头比较。
Transl Neurodegener. 2023 Jun 29;12(1):34. doi: 10.1186/s40035-023-00365-x.
6
A multidimensional ODE-based model of Alzheimer's disease progression.基于多维 ODE 的阿尔茨海默病进展模型。
Sci Rep. 2023 Feb 23;13(1):3162. doi: 10.1038/s41598-023-29383-5.
7
MC-RVAE: Multi-channel recurrent variational autoencoder for multimodal Alzheimer's disease progression modelling.MC-RVAE:用于多模态阿尔茨海默病进展建模的多通道递归变分自动编码器。
Neuroimage. 2023 Mar;268:119892. doi: 10.1016/j.neuroimage.2023.119892. Epub 2023 Jan 20.
8
Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models.使用机器学习模型预测早期阿尔茨海默病。
Front Public Health. 2022 Mar 3;10:853294. doi: 10.3389/fpubh.2022.853294. eCollection 2022.
9
A Long Short-Term Memory Biomarker-Based Prediction Framework for Alzheimer's Disease.基于长短期记忆生物标志物的阿尔茨海默病预测框架。
Sensors (Basel). 2022 Feb 14;22(4):1475. doi: 10.3390/s22041475.
10
Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.阿尔茨海默病诊断和进展率的异质性:对治疗试验的影响。
Neurotherapeutics. 2022 Jan;19(1):8-25. doi: 10.1007/s13311-022-01185-z. Epub 2022 Jan 27.